Body Imaging


Peter A. Loud, MD
Associate Professor of Radiology
SUNY at Buffalo

Thomas Laudico, DO 
Charles Roche, MD
Janine Milligan, DO
Lalit K. Gurtoo, MD
Peter Klieger, MD
Alan Klitzke, MD
Prasanna R. G. Kumar, MD
Roger M. Smith, MD
Craig Hendler, MD
Timothy Hanna, RPA-C
Ghinita Burbulea, RPA-C
Vaughn Sheeran, RPA-C

Selected Publications

Cheson Bd, Horning Sj, Coiffier B, Shipp Ma, Fisher Rl, Connors Jm, Lister Ta, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippenstein Dl, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 17: 1244-1253,1999.

Stomper PC, Waddell BE, Edge SB, Klippenstein DL. Breast MRI in the evaluation of patients with occult primary breast carcinoma. The Breast J 5:230-234, 1999.

Loud PA, Katz DS, Klippenstein DL, Shah RA, Grossman ZD. Combined CT Venography and Pulmonary Angiography in Suspected Thromboembolic Disease: Diagnostic Accuracy for Deep Venous Evaluation. American Journal of Roentgenology 2000;174:61-65

Katz DS, Loud PA, Klippenstein DL, Shah RA, Grossman ZD. Extra-Thoracic Findings on the Venous Phase of Combined Computed Tomographic Venography and Pulmonary Angiography (Pictorial Essay). Clinical Radiology 2000; 55:177-181

Federle MP, Chezmar JL, Rubin DL, Weinreb JC, Freeny PC, Semelka RC, Brown JJ, Borrello JA, Lee JKT, Mattrey R, Dachman AH, Saini S, Harmon B, Fenstermacher M, Pelsang RE, Harms SE, Mitchell DG, Halford HH, Anderson MW, Johnson CD, Francis IR, Bova JG, Kenney PJ, Klippenstein DL, et al. Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). JMRI 2000; 12:186-197

Grillo-Lopez AJ, Cheson BD, Horning SJ, Peterson BA, Carter WD, Varns CL, Klippenstein DL, Shen CD. Response criteria for NHL: Importance of "normal" lymph node size and correlations with response rates. Annals of Oncology 2000; 11:399-408

Czuczman MS, Grillo-Lopez AJ, White CA. Saleh M, Gorden L. LoBuglio AF, Jonas C, Klippenstein D, Dallaire B, Varns C. The treatment of patients low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody (Rituxan, Rituximab) and CHOP chemotherapy. Journal of Clinical Oncology 1999; 17:268-276